Singapore markets closed

Athira Pharma, Inc. (ATHA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.0900-0.0400 (-1.88%)
At close: 04:00PM EDT
2.1500 +0.06 (+2.87%)
After hours: 05:19PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
93,790
93,790
61,464
42,794
13,286
Selling general and administrative
33,304
33,304
32,552
21,228
6,709
Total operating expenses
126,937
126,937
88,855
55,187
18,674
Operating income or loss
-126,937
-126,937
-88,855
-55,187
-18,674
Interest expense
-
-
-
3
367
Total other income/expenses net
9,265
9,265
-6,784
334
-1,038
Income before tax
-117,672
-117,672
-95,639
-54,853
-19,955
Income from continuing operations
-117,672
-117,672
-95,639
-54,853
-19,955
Net income
-117,672
-117,672
-95,639
-54,853
-19,955
Net income available to common shareholders
-117,672
-117,672
-95,639
-55,274
-19,955
Basic EPS
-3.17
-
-2.53
-1.49
-1.67
Diluted EPS
-3.17
-
-2.53
-1.49
-1.67
Basic average shares
37,958
-
37,733
36,921
11,967
Diluted average shares
37,958
-
37,733
36,921
11,967